Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

2.13
+0.15007.58%
Pre-market: 2.130.00000.00%04:48 EDT
Volume:9.18M
Turnover:19.63M
Market Cap:79.71M
PE:-1.45
High:2.22
Open:2.06
Low:2.04
Close:1.98
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:1.33
T/O Rate:52.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.70
PE(LYR):-1.59

Loading ...

Tenax Therapeutics Releases LEVEL Clinical Trial Results Presentation

Reuters
·
Yesterday

ADAR1 Capital’s Daniel Schneeberger Buys $1.6 Million of Tenax Therapeutics Shares

Reuters
·
Yesterday

ADAR1 Capital Management Reports Tenax Therapeutics Common Share Purchase Worth $1.38 Million

Reuters
·
Sep 03

Tenax Therapeutics CEO to Present at Cantor Global Healthcare Conference

Reuters
·
Sep 01

Piper Sandler Sticks to Their Buy Rating for Tenax Therapeutics (TENX)

TIPRANKS
·
Aug 31

Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103

TIPRANKS
·
Aug 31

Tenax Presents Phase 3 LEVEL Data Showing TNX-103 Boosts 6-Minute Walk Distance in Lower Baseline Subgroup

Reuters
·
Aug 29

Tenax Therapeutics Discloses ADAR1 Capital Management as Beneficial Owner in Form 3 Filing

Reuters
·
Aug 25

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

Tenax Therapeutics downgraded to Neutral from Buy at Chardan

TIPRANKS
·
Aug 11

Tenax Therapeutics Price Target Cut to $5.00/Share from $39.00 by Evercore ISI Group

Dow Jones
·
Aug 11

Evercore ISI Downgrades Tenax Therapeutics to In Line From Outperform, Adjusts PT to $5 From $39

MT Newswires Live
·
Aug 11

Tenax Therapeutics Inc : William Blair Cuts to Market Perform Rating

THOMSON REUTERS
·
Aug 11

Tenax Therapeutics price target lowered to $4 from $26 at Leerink

TIPRANKS
·
Aug 11

Tenax Therapeutics Inc : Canaccord Genuity Cuts Target Price to $4 from $35

THOMSON REUTERS
·
Aug 11

Tenax Therapeutics downgraded to Market Perform from Outperform at William Blair

TIPRANKS
·
Aug 11

U.S. Stocks on the MOVE-Microsoft, Coastal Financial

Reuters
·
Aug 11

Tenax, Sionna Shares Sink After Trial Failures

Dow Jones
·
Aug 10

Tenax Therapeutics Exec Says Two Deaths Occurred During Double-Blind Phase, with Investigators Determining Both were Unrelated to Tnx-103- Conf Call

THOMSON REUTERS
·
Aug 10

Quanterix Q2 Revenue Rises 34% but Cuts 2026 Outlook

Reuters
·
Aug 10